Lane Milde
Director, Global Sample Management Takeda Pharmaceutical
Lane Milde is a specialist in laboratory automation, robotics, and liquid handling, with extensive experience in designing, building, and programming integrated liquid and microplate handling systems. He has a strong track record of transforming manual assays into efficient, automated workflows to enhance throughput and reproducibility.
Lane’s interdisciplinary expertise spans robotics programming, process improvement, quality control, assay optimization and miniaturization, and genomics, alongside a broad range of molecular biology techniques. He is particularly focused on driving innovation in lab automation to improve operational efficiency and enable scalable scientific workflows.
Seminars
- Maximizing return on limited capital budgets by directing investment toward the highest-risk infrastructure assets, avoiding low-impact spend while preventing failures that drive downtime, emergency repairs, and lost research output
- Reducing unplanned outages and lifecycle cost creep by using risk-based prioritisation to address ageing, high-criticality systems before they become operational or compliance liabilities
- Enabling faster, more defensible capital decisions by applying transparent, data-driven frameworks that align engineering, finance, and leadership around where investment delivers the greatest protection and long-term value
If a major disruption hits tomorrow, a supply chain collapses, a regulatory shock, or an extreme weather event, how confident are you that your lab or site could keep operating? Would your teams know the early warning signs, the decision triggers, and the actions to take?
- Navigate through 3-4 realistic disruption scenarios to expose operational weaknesses across assets, staffing, digital systems, and vendors
- Evaluate the impact of disruptions on critical workflows and identify where resilience gaps pose the highest risk
- Craft a Resilience Playbook including early-warning indicators, decision triggers, response actions, and communication pathways
